Sanofi SA (France) Performance
| SAN Stock | EUR 92.10 0.21 0.23% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Sanofi SA are completely uncorrelated. At this point, Sanofi SA has a negative expected return of -0.2%. Please make sure to validate Sanofi SA's accumulation distribution, as well as the relationship between the day median price and period momentum indicator , to decide if Sanofi SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sanofi SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 10.1 B |
Sanofi |
Sanofi SA Relative Risk vs. Return Landscape
If you would invest 10,486 in Sanofi SA on August 31, 2024 and sell it today you would lose (1,276) from holding Sanofi SA or give up 12.17% of portfolio value over 90 days. Sanofi SA is producing return of less than zero assuming 1.0471% volatility of returns over the 90 days investment horizon. Simply put, 9% of all stocks have less volatile historical return distribution than Sanofi SA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sanofi SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sanofi SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sanofi SA, and traders can use it to determine the average amount a Sanofi SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1883
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SAN |
Estimated Market Risk
| 1.05 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sanofi SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sanofi SA by adding Sanofi SA to a well-diversified portfolio.
Sanofi SA Fundamentals Growth
Sanofi Stock prices reflect investors' perceptions of the future prospects and financial health of Sanofi SA, and Sanofi SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sanofi Stock performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0559 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.24 % | |||
| Current Valuation | 128.44 B | |||
| Shares Outstanding | 1.25 B | |||
| Price To Earning | 8.63 X | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 2.53 X | |||
| Revenue | 45.39 B | |||
| EBITDA | 13.77 B | |||
| Cash And Equivalents | 9.72 B | |||
| Cash Per Share | 7.76 X | |||
| Total Debt | 14.86 B | |||
| Debt To Equity | 0.34 % | |||
| Book Value Per Share | 59.70 X | |||
| Cash Flow From Operations | 10.53 B | |||
| Earnings Per Share | 6.66 X | |||
| Total Asset | 124.58 B | |||
About Sanofi SA Performance
By analyzing Sanofi SA's fundamental ratios, stakeholders can gain valuable insights into Sanofi SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sanofi SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sanofi SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was incorporated in 1994 and is headquartered in Paris, France. SANOFI operates under Drug ManufacturersGeneral classification in France and is traded on Paris Stock Exchange. It employs 99412 people.Things to note about Sanofi SA performance evaluation
Checking the ongoing alerts about Sanofi SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sanofi SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sanofi SA generated a negative expected return over the last 90 days |
- Analyzing Sanofi SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sanofi SA's stock is overvalued or undervalued compared to its peers.
- Examining Sanofi SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sanofi SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sanofi SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sanofi SA's stock. These opinions can provide insight into Sanofi SA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sanofi Stock analysis
When running Sanofi SA's price analysis, check to measure Sanofi SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi SA is operating at the current time. Most of Sanofi SA's value examination focuses on studying past and present price action to predict the probability of Sanofi SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi SA's price. Additionally, you may evaluate how the addition of Sanofi SA to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |